This morning, Intec Pharma Ltd. (TASE:NTEC)(NASDAQ:NTEC) announced that the company has promoted its Executive Vice President-Research & Development and Operations, Nadav Navon, Ph.D, to Chief Operating Officer, effective immediately.
Dr. Navon has been with Intec Pharma since 2006 and has served in his most recent position (before being appointed COO) since March 2015. Before that, he served as Vice President of Research & Development and Operations.
Prior to joining Intec, Dr. Navon worked at Sharon Laboratories Ltd. and conducted research at the Negev Nuclear Research Center. Dr. Navon earned his Bachelor of Science in chemistry, his MBA and a Ph.D. in inorganic and analytical chemistry at Ben-Gurion University in Israel.
Related: Tel Aviv Listed Marijuana Stocks
Intec's Chief Executive Officer, Jeffrey A. Meckler had this to say about Dr. Navon's promotion:
"Dr. Navon has been instrumental in the growth and development of Intec Pharma since he joined the team in 2006. He has an outstanding track record in operations having lead the development of the Accordion Pill through a number of important clinical studies on to our pivotal Phase 3 clinical trial of the Accordion Pill Carbidopa/Levodopa (AP-CD/LD) for the treatment of advanced Parkinson's disease symptoms. Importantly, Dr. Navon's intricate knowledge of our AP technology platform and the numerous patents he has filed on behalf of the company will be of great value as we advance our Parkinson's program. As Chief Operating Officer, Dr. Navon will continue to play a key role on our senior management team, particularly in the oversight of our Israeli operations. I look forward to continuing to work with him as we build Intec Pharma into a world class biopharmaceutical company."
Learn more about Intec Pharma by checking out the company's marijuana stock profile in our cannabinoid biotech stock database. Don't forget that shares of Intec Pharma can be traded commission free using the Robinhood App.
Also, be sure to subscribe to one or more of our free email newsletters so you never miss an important update. If you haven't already, connect with The Daily Marijuana Observer on social media via Facebook, Twitter, StockTwits, and Instagram.
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.